Keybank National Association OH Purchases New Stake in Iqvia Holdings Inc (IQV)

Keybank National Association OH purchased a new stake in Iqvia Holdings Inc (NYSE:IQV) during the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 1,799 shares of the medical research company’s stock, valued at approximately $209,000.

A number of other hedge funds also recently bought and sold shares of the business. Contravisory Investment Management Inc. raised its position in Iqvia by 7.1% in the 4th quarter. Contravisory Investment Management Inc. now owns 2,614 shares of the medical research company’s stock valued at $304,000 after purchasing an additional 174 shares in the last quarter. Raymond James Trust N.A. raised its position in Iqvia by 10.0% in the 4th quarter. Raymond James Trust N.A. now owns 3,254 shares of the medical research company’s stock valued at $377,000 after purchasing an additional 295 shares in the last quarter. DNB Asset Management AS raised its position in Iqvia by 0.3% in the 4th quarter. DNB Asset Management AS now owns 111,722 shares of the medical research company’s stock valued at $12,979,000 after purchasing an additional 300 shares in the last quarter. CENTRAL TRUST Co raised its position in Iqvia by 1,150.0% in the 4th quarter. CENTRAL TRUST Co now owns 375 shares of the medical research company’s stock valued at $44,000 after purchasing an additional 345 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. raised its position in shares of Iqvia by 1.9% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 25,186 shares of the medical research company’s stock worth $3,268,000 after acquiring an additional 461 shares in the last quarter. 93.62% of the stock is currently owned by institutional investors.

NYSE:IQV opened at $131.82 on Thursday. The company has a market cap of $26.34 billion, a P/E ratio of 30.23, a PEG ratio of 1.59 and a beta of 0.88. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 1.41. Iqvia Holdings Inc has a 52-week low of $91.57 and a 52-week high of $139.65.

In other Iqvia news, Director Group Holdings (Sbs) Advis Tpg sold 3,573,545 shares of Iqvia stock in a transaction that occurred on Tuesday, December 4th. The stock was sold at an average price of $123.72, for a total value of $442,118,987.40. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Ronald A. Rittenmeyer sold 3,840 shares of Iqvia stock in a transaction that occurred on Tuesday, February 5th. The shares were sold at an average price of $130.00, for a total value of $499,200.00. The disclosure for this sale can be found here. Insiders have sold a total of 6,751,273 shares of company stock worth $835,335,596 in the last 90 days. 6.00% of the stock is currently owned by company insiders.

Several equities research analysts have recently weighed in on the company. Morgan Stanley raised their target price on Iqvia from $130.00 to $145.00 and gave the stock an “overweight” rating in a research report on Monday, December 3rd. Jefferies Financial Group raised Iqvia from a “hold” rating to a “buy” rating and raised their target price for the stock from $136.00 to $150.00 in a research report on Friday, January 18th. Goldman Sachs Group raised Iqvia from a “buy” rating to a “conviction-buy” rating in a research report on Friday, January 11th. Royal Bank of Canada raised their target price on Iqvia to $137.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 23rd. Finally, Zacks Investment Research lowered Iqvia from a “buy” rating to a “hold” rating in a research report on Thursday, October 25th. Three investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the stock. Iqvia currently has a consensus rating of “Buy” and a consensus target price of $139.47.

ILLEGAL ACTIVITY NOTICE: “Keybank National Association OH Purchases New Stake in Iqvia Holdings Inc (IQV)” was first reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of United States and international copyright and trademark legislation. The correct version of this piece of content can be accessed at https://www.chaffeybreeze.com/2019/02/14/keybank-national-association-oh-purchases-new-stake-in-iqvia-holdings-inc-iqv.html.

About Iqvia

IQVIA Holdings Inc provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers a range of cloud-based applications and related implementation, real-world insights, and reference information services; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.

Featured Story: How to Invest in the Dividend Aristocrat Index

Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Iqvia Holdings Inc (NYSE:IQV).

Institutional Ownership by Quarter for Iqvia (NYSE:IQV)

Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply